Latest Articles

Publication Date
Singapore start-up raises US$1.5m to redefine menstrual health - FemTech World

Singapore start-up raises US$1.5m to redefine menstrual health FemTech World

Published: Feb. 16, 2026, 2:50 p.m.
‘I thought it was depression’: How PMDD was misdiagnosed - and the FemTech revolution changing women’s health - The Independent

‘I thought it was depression’: How PMDD was misdiagnosed - and the FemTech revolution changing women’s health The Independent

Published: Feb. 16, 2026, 7 a.m.
‘I thought my PMDD was depression - How Femtech revolution is changing women’s health - The Independent

‘I thought my PMDD was depression - How Femtech revolution is changing women’s health The Independent

Published: Feb. 16, 2026, 7 a.m.
A Previous History of Endometriosis Elevates Irritable Bowel Syndrome Risk in Middle-Aged and Older Women: A UK Biobank Cohort Study of 225,703 Participants.

Endometriosis (EMT) and irritable bowel syndrome (IBS) disproportionately affect middle-aged and older women, where overlapping symptoms (e.g., chronic pelvic pain, bloating) and shared inflammatory mechanisms may drive comorbidity. However, large-scale …

Published: Feb. 16, 2026, midnight
SGS Partners with Germany-based theblood to Validate Menstrual Blood Diagnostics - Femtech Insider

SGS Partners with Germany-based theblood to Validate Menstrual Blood Diagnostics Femtech Insider

Published: Feb. 12, 2026, 11:42 a.m.
Research project of the year: What the judges want to see - FemTech World

Research project of the year: What the judges want to see FemTech World

Published: Feb. 11, 2026, 8:36 a.m.
Amygdalin inhibits 17β-estradiol-induced mesenchymal transition through TGF- β/Smad signaling in normal and endometriotic endometrial epithelial cells.

Endometriosis is a common gynecological disorder characterized by chronic pelvic pain, infertility, and systemic symptoms, with currently limited treatment options. Amygdalin, a cyanogenic glycoside derived from bitter apricot kernels, has …

Published: Feb. 11, 2026, midnight
FBXW7 suppresses cell proliferation, migration, and epithelial-mesenchymal transition in endometrioid ovarian carcinoma.

Epithelial ovarian carcinoma is a common gynecologic malignancy. Evidence from several studies suggests that subtypes of this cancer-specifically clear-cell ovarian carcinoma and endometrioid ovarian carcinoma (ENOC)-are associated with endometriosis. FBXW7 …

Published: Feb. 11, 2026, midnight
Pioneering femtech startup Amilis wins bid to represent the capital at ‘world cup of innovation’ in Tokyo - London Daily News

Pioneering femtech startup Amilis wins bid to represent the capital at ‘world cup of innovation’ in Tokyo London Daily News

Published: Feb. 9, 2026, 3:41 p.m.
The hidden cost of “business as usual” in gynecologic surgery - FemTech World

The hidden cost of “business as usual” in gynecologic surgery FemTech World

Published: Feb. 6, 2026, 12:05 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!